Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy

Overview of attention for article published in Frontiers in Pharmacology, January 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 4 X users

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 29 Mendeley

Summary X Wikipedia Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 37,111 followers.

RT @shababaty: @PhilProton @LoreGrilloJ @nlm_news @NHSuk @NIHRresearch El Bemcentinib es un medicamento desarrollado originalmente con éxit…

03 May 2020

Reply Repost Favourite

@PhilProton @LoreGrilloJ @nlm_news @NHSuk @NIHRresearch El Bemcentinib es un medicamento desarrollado originalmente con éxito contra el cancer de pulmón Por que neutraliza la proteina natural AXL, proteina que han descubierto, ahora, permite al Covid19 s

03 May 2020

Reply Repost Favourite

Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy. https://t.co/9AvRxp5YVE

30 Jan 2018

Reply Repost Favourite

Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy https://t.co/rHtOZI7wEe

11 Jan 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.